BioXcel Therapeutics, Inc. Gains 55.01%

Fri 14 Feb 20 at 05:30 PM
BioXcel Therapeutics, Inc. Gains 55.01%

BioXcel Therapeutics, Inc. (BTAI:NASDAQ) jumped higher at $36.97, a gain of 55%. On Thu 13 Feb 20, BTAI:NASDAQ touched a New 2-Week High of $23.85. The stock got featured on our News Catalysts scanner on Fri 07 Feb 20 at 08:23 AM in the 'MISCELLANEOUS' category. From Fri 24 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days

About BioXcel Therapeutics, Inc. (BTAI:NASDAQ)

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.